
Revolutionizing Ectoparasite Management for Veterinary Practices
The veterinary landscape is undergoing a significant transformation with the introduction of isoxazoline parasiticides, fundamentally changing how ectoparasites are managed in small animal practices. In a recent episode of Vet Watch, veterinary experts Alice Jeromin, DVM, RPh, DACVD, and Christopher Lee, DVM, MPH, DACVPM, delve into how these modern compounds are becoming the gold standard in parasite control, ensuring both efficacy and safety.
From Old-School Treatments to Modern Solutions
Gone are the days of cumbersome and often unsafe treatments like amitraz dips and pyrethrin sprays. According to Jeromin, early methods not only consumed extensive clinic time but also posed safety risks to pets and their handlers. Isoxazolines, such as fluralaner and sarolaner, revolutionize ectoparasite management by providing rapid knockdown of parasites while selectively binding to invertebrate neuronal receptors—thus sparing mammalian ones.
Broader Applications Beyond Fleas and Ticks
In addition to their core applications for fleas and ticks, isoxazolines have demonstrated promising extra-label uses in veterinary dermatology. Jeromin highlights the impressive efficacy of a single dose in managing Demodex mange, previously controlled through lengthy courses of macrocyclic lactones. Lee notes that similar protocols have led to successful control over Sarcoptes scabiei and Otodectes cynotis, minimizing the need for more toxic off-label products.
Importance of Educating Pet Owners
As with any medical treatment, the success of isoxazolines relies heavily on proper administration and education. Jeromin recommends performing routine oil-based ear cytology to identify otodectic mites, particularly in chronic otitis patients. Ensuring pet owners are well-informed about medication protocols, including feeding instructions, is crucial to maximize drug absorption and effectiveness.
Year-Round Ectoparasite Control is Essential
Both specialists stress the need for year-round parasite prevention, especially for indoor pets at risk from external sources. Jeromin and Lee’s collective insight provides a compelling case for veterinary practitioners to proactively incorporate isoxazolines into their treatment protocols, thus enhancing the quality of care offered to both pets and their owners.
As the veterinary field continues to embrace these advancements, it’s essential for clinic owners and managers to adapt their practices, ensuring they leverage isoxazolines to improve patient outcomes and client satisfaction.
Write A Comment